{"gene":"POLE","run_date":"2026-04-28T19:45:44","timeline":{"discoveries":[{"year":2012,"finding":"Germline mutations in the proofreading (exonuclease) domain of POLE (p.Leu424Val) cause defects in correction of mispaired bases inserted during DNA replication, leading to base substitution hypermutation in tumors while remaining microsatellite stable. Yeast functional assays confirmed loss of exonuclease proofreading activity.","method":"Whole-genome sequencing, linkage/association analysis, yeast functional assays for exonuclease activity","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 1 — foundational paper with multiple orthogonal methods (WGS, functional yeast assay), highly cited, replicated across labs","pmids":["23263490"],"is_preprint":false},{"year":2020,"finding":"POLE exonuclease domain mutations (EDMs) cause loss of proofreading function, generating a characteristic mutational signature including >20% C>A substitutions, >4% T>G substitutions, <0.6% C>G substitutions, and tumor mutational burden >100 mut/Mb. A scoring system (POLE-score) based on these genomic alterations distinguishes pathogenic from non-pathogenic POLE mutations. Mutations outside the exonuclease domain are predominantly not pathogenic.","method":"Whole-exome sequencing of TCGA endometrial carcinomas, mutational signature analysis, POLE-score development","journal":"The Journal of pathology","confidence":"High","confidence_rationale":"Tier 2 — systematic multi-parameter genomic analysis across large cohort, mechanistically defines pathogenic vs. non-pathogenic variants","pmids":["31829442"],"is_preprint":false},{"year":2020,"finding":"POLE cancer mutant alleles drive characteristic mutational signature accumulation even in the presence of functional mismatch repair (MMR), unlike an exonuclease active-site mutant. The relative abundance of mutation signatures partitions POLE tumors into distinct subgroups dependent on the specific POLE allele, its expression level, and MMR status, revealing that different POLE mutants have distinct effects on replication fidelity.","method":"CRISPR-Cas9 engineering of human cell lines expressing POLE tumor variants with/without MMR, whole-exome sequencing after defined population doublings","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 — reconstitution in human cells with CRISPR engineering, quantitative mutation accumulation assay, multiple POLE alleles compared","pmids":["32497495"],"is_preprint":false},{"year":2019,"finding":"POLE proofreading-deficient tumors accumulate extensive somatic mutations via loss of exonuclease proofreading activity during DNA replication. The proofreading domain of POLE corrects mispaired bases; mutations in this domain allow errors to persist, leading to hypermutation. MMR further modulates the mutational spectrum.","method":"Cancer genome sequencing, mutational signature analysis, review of yeast and mouse model data","journal":"DNA repair","confidence":"High","confidence_rationale":"Tier 2 — comprehensive review integrating multiple independent experimental systems (yeast, mouse, human cells)","pmids":["30818169"],"is_preprint":false},{"year":2015,"finding":"A novel POLE mutation (p.Tyr458Phe) located in the active site of the exonuclease domain affects a residue previously shown to be important for exonuclease activity, expanding the tumor spectrum of POLE mutation carriers to include cancers of colon, pancreas, ovaries, and small intestine.","method":"Exome sequencing, pedigree analysis, identification of active-site residue involved in exonuclease catalysis","journal":"Familial cancer","confidence":"Medium","confidence_rationale":"Tier 2 — exome sequencing with structural/functional annotation of active-site residue; single family","pmids":["25860647"],"is_preprint":false},{"year":2014,"finding":"The POLE mutation p.Asn363Lys (c.1089C>A) is located in the proofreading exonuclease domain at a residue directly involved in DNA binding, predicted to profoundly affect substrate binding capability and catalytic activity of the exonuclease, leading to a broader tumor spectrum than p.Leu424Val.","method":"Sequencing, in silico structural prediction of amino acid substitution effect on DNA binding","journal":"International journal of oncology","confidence":"Medium","confidence_rationale":"Tier 3 — in silico prediction with family segregation data, no direct in vitro enzymatic assay","pmids":["24788313"],"is_preprint":false},{"year":2015,"finding":"POLE exonuclease domain mutations generate ultra-mutated tumors with a high neoantigen load, inducing robust tumor-specific CD4+ T cell responses and a Th1 cytokine bias (IFN-γ), and significantly more immunogenic responses compared to POLE wild-type endometrial cancers.","method":"Autologous dendritic cell stimulation assay, CFSE proliferation assay, [3H]-thymidine incorporation, 51Cr cytotoxicity assay, intracellular cytokine flow cytometry","journal":"Gynecologic oncology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple in vitro functional immunological assays establishing mechanistic immunogenicity link; single lab","pmids":["25931171"],"is_preprint":false},{"year":2017,"finding":"A POLE variant (c.1420G>A, p.Val474Ile) located adjacent to the exonuclease domain was shown by functional assays in Schizosaccharomyces pombe to impair proofreading activity, representing the first functional analysis of a POLE variant outside the canonical exonuclease domain.","method":"Sanger sequencing, bioinformatics prediction, S. pombe functional assay for proofreading activity","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 1 — functional yeast assay validating proofreading defect; single study","pmids":["28423643"],"is_preprint":false},{"year":2022,"finding":"Pathogenic POLE/POLD1 mutations that cause functional proofreading deficiency generate specific mutational signatures and produce neoantigens with increased hydrophobicity at TCR-contact residues, facilitating T cell recognition and enhancing immune checkpoint blockade response. Murine syngeneic tumors with Pole/Pold1 functional mutations displayed enhanced antitumor immunity sensitive to ICB.","method":"Murine syngeneic tumor models, mutational signature analysis, biochemical analysis of neoantigen properties, patient ICB response correlation","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 — mechanistic study with animal models plus biochemical neoantigen characterization, published in high-impact journal","pmids":["35817971"],"is_preprint":false},{"year":2019,"finding":"Defective POLE proofreading leads to extensive somatic mutation accumulation following a temporally ordered pattern: mutations in cancer-related genes occur before the aberrant POLE event, PTEN mutations co-occur with or follow POLE mutations, and homologous recombination is restored after PTEN mutation, suggesting POLE and PTEN cooperate in tumorigenic development.","method":"Whole-exome sequencing of 10 POLE-mutated solid tumors, sequential mutation shift analysis","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — systematic genomic analysis establishing temporal ordering of mutational events; single cohort","pmids":["29880869"],"is_preprint":false},{"year":2015,"finding":"POLE exonuclease domain mutations co-occurring with MMR deficiency/MSI-H produce genomic alterations characteristic of POLE-ultramutated tumors, indicating that the POLE proofreading defect is dominant over MMR deficiency in determining the mutational phenotype when both are present.","method":"Exome sequencing, MMR protein IHC, MSI analysis, mutational signature analysis in combined MMR-deficient/POLE-mutated tumors","journal":"European journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 2 — epistasis established by combined molecular analysis; moderate sample size","pmids":["26648449"],"is_preprint":false},{"year":2015,"finding":"A patient with homozygous POLE1 (catalytic subunit of DNA polymerase epsilon) splice variant (c.4444+3A>G) presented with growth retardation, microcephaly, developmental delay, immune deficiency with pancytopenia, and myelodysplasia, demonstrating that complete loss of POLE1 function causes a chromosome instability syndrome in humans.","method":"Exome sequencing, clinical phenotyping","journal":"BMC medical genetics","confidence":"Medium","confidence_rationale":"Tier 2 — human loss-of-function with defined clinical/cellular phenotype; single patient report","pmids":["25948378"],"is_preprint":false},{"year":2014,"finding":"POLE somatic exonuclease domain mutations (including P286R, V411L) define an ultramutated endometrial carcinoma subtype characterized by microsatellite stability, high tumor mutation rate, and distinct co-mutations in PTEN, FBXW7, ARID1A, and PIK3CA, establishing POLE proofreading defects as a driver of hypermutation distinct from MMR deficiency.","method":"Sanger sequencing of POLE exonuclease domain, TCGA whole-exome sequencing data analysis, microsatellite stability testing","journal":"Modern pathology","confidence":"High","confidence_rationale":"Tier 2 — systematic molecular characterization across TCGA cohort plus independent validation cohort, replicated","pmids":["25394778"],"is_preprint":false}],"current_model":"POLE encodes the catalytic subunit of DNA polymerase epsilon, which functions in leading-strand DNA replication and possesses an intrinsic 3'→5' proofreading exonuclease activity; missense mutations in the exonuclease domain abolish proofreading of mispaired bases, causing extreme hypermutation with a characteristic mutational signature (enriched for C>A and T>G transversions, MSS), while the identity of the specific mutant allele, its expression level, and concurrent MMR status modulate the exact spectrum and burden of accumulated mutations, and the resulting neoantigen load drives enhanced immunogenicity and response to immune checkpoint blockade."},"narrative":{"teleology":[{"year":2012,"claim":"Establishing that germline POLE exonuclease domain mutations (p.Leu424Val) cause loss of proofreading during replication answered the foundational question of how proofreading polymerase defects drive base-substitution hypermutation without microsatellite instability.","evidence":"Whole-genome sequencing of familial colorectal cancer kindreds plus yeast functional assays confirming exonuclease activity loss","pmids":["23263490"],"confidence":"High","gaps":["Mechanism by which specific residue substitutions differentially affect polymerase fidelity was not resolved","Spectrum of pathogenic versus non-pathogenic POLE variants not yet delineated","Contribution of MMR as a secondary correction mechanism not quantified"]},{"year":2014,"claim":"Systematic molecular characterization of endometrial carcinomas showed that somatic POLE exonuclease domain mutations (P286R, V411L) define an ultramutated tumor subtype mechanistically distinct from MMR-deficient tumors, establishing POLE proofreading defects as an independent driver of hypermutation in sporadic cancer.","evidence":"Sanger sequencing plus TCGA whole-exome data with microsatellite stability testing in endometrial carcinoma cohorts","pmids":["25394778"],"confidence":"High","gaps":["No direct enzymatic measurement of polymerase fidelity for the somatic mutants in human cells","Cooperative role of co-mutated genes (PTEN, PIK3CA) not mechanistically tested"]},{"year":2015,"claim":"Demonstrating that POLE-ultramutated tumors generate high neoantigen loads eliciting robust CD4+ Th1 immune responses linked POLE proofreading deficiency to tumor immunogenicity, answering why these hypermutated cancers paradoxically have favorable outcomes.","evidence":"Autologous dendritic cell stimulation, CFSE proliferation, 51Cr cytotoxicity, and intracellular cytokine assays in POLE-mutant versus wild-type endometrial cancers","pmids":["25931171"],"confidence":"Medium","gaps":["CD8+ cytotoxic responses and in vivo immune killing not directly measured","Contribution of specific neoantigens versus total burden not dissected","Single-lab study without independent replication"]},{"year":2015,"claim":"A homozygous POLE splice variant causing complete loss of function resulted in a chromosome instability syndrome with microcephaly, immune deficiency, and myelodysplasia, establishing that POLE is essential for normal human development beyond its cancer-proofreading role.","evidence":"Exome sequencing and clinical phenotyping of a single patient with homozygous POLE1 splice variant","pmids":["25948378"],"confidence":"Medium","gaps":["Single patient; no complementation or rescue experiment performed","Whether the developmental phenotype reflects replication defects, DNA repair defects, or both is unresolved","Cellular mechanism of chromosome instability not characterized"]},{"year":2015,"claim":"Epistasis analysis showed that when POLE exonuclease domain mutations co-occur with MMR deficiency, the POLE mutational signature dominates, establishing the hierarchical relationship between these two DNA fidelity mechanisms.","evidence":"Exome sequencing, MMR protein IHC, MSI analysis, and mutational signature comparison in doubly-deficient tumors","pmids":["26648449"],"confidence":"Medium","gaps":["Mechanism of dominance (e.g., error rate versus error type) not dissected biochemically","Limited sample size of concurrent POLE/MMR-deficient cases"]},{"year":2020,"claim":"CRISPR-engineered human cells expressing specific POLE tumor variants revealed that different mutant alleles produce distinct mutational signatures even with intact MMR, resolving the question of whether allele identity or MMR status is the primary determinant of mutational spectrum.","evidence":"CRISPR-Cas9 knock-in of POLE variants in human cell lines with/without MMR, whole-exome sequencing after defined population doublings","pmids":["32497495"],"confidence":"High","gaps":["Biochemical basis for allele-specific signature differences (e.g., altered base selectivity) not determined","Long-term fitness consequences of different POLE alleles not assessed"]},{"year":2020,"claim":"Development of the POLE-score system using signature-based genomic criteria (C>A >20%, T>G >4%, TMB >100 mut/Mb) distinguished pathogenic from non-pathogenic POLE variants, answering the variant-interpretation problem that had accumulated since the initial discovery.","evidence":"Systematic whole-exome sequencing analysis of TCGA endometrial carcinomas with mutational signature quantification","pmids":["31829442"],"confidence":"High","gaps":["POLE-score validated only in endometrial cancer; applicability to other tumor types not established","No direct enzymatic assay validation of scored variants"]},{"year":2022,"claim":"Mechanistic characterization of POLE/POLD1-driven neoantigens revealed increased hydrophobicity at TCR-contact residues, explaining enhanced T cell recognition and providing a biochemical basis for the exceptional immune checkpoint blockade response seen in POLE-mutant tumors.","evidence":"Murine syngeneic tumor models with Pole mutations, neoantigen biochemical property analysis, patient ICB response correlation","pmids":["35817971"],"confidence":"High","gaps":["Whether hydrophobicity-driven immunogenicity generalizes beyond the tested neoantigen repertoire is unclear","Relative contribution of POLE versus POLD1 neoantigens to immunogenicity not separated","No structural data on TCR–neoantigen interactions"]},{"year":null,"claim":"The structural and biochemical basis by which individual POLE exonuclease domain substitutions differentially alter nucleotide selectivity and fidelity—and how the resulting mutational processes interact with chromatin context and replication timing—remains unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No high-resolution structure of human POLE holoenzyme with mutant exonuclease domain","Allele-specific differences in polymerase kinetics not measured in vitro with purified human enzyme","Relationship between replication timing, chromatin state, and POLE-driven mutagenesis not established"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140097","term_label":"catalytic activity, acting on DNA","supporting_discovery_ids":[0,2,3]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,5]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,2,11]}],"pathway":[{"term_id":"R-HSA-69306","term_label":"DNA Replication","supporting_discovery_ids":[0,2,3,12]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[0,3]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[1,2,8,12]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[6,8]}],"complexes":["DNA polymerase epsilon"],"partners":["POLD1","PTEN"],"other_free_text":[]},"mechanistic_narrative":"POLE encodes the catalytic subunit of DNA polymerase epsilon, which carries out leading-strand DNA replication and harbors an intrinsic 3'→5' exonuclease domain that proofreads mispaired bases during synthesis. Germline or somatic missense mutations in the exonuclease domain—such as p.Leu424Val, P286R, and V411L—abolish proofreading activity, producing microsatellite-stable, ultramutated tumors (>100 mut/Mb) with a characteristic mutational signature enriched for C>A and T>G transversions; the specific mutant allele, its expression level, and concurrent mismatch repair status determine the exact mutational spectrum and burden [PMID:23263490, PMID:32497495, PMID:31829442, PMID:25394778]. The resulting high neoantigen load, including neoantigens with increased hydrophobicity at TCR-contact residues, drives robust CD4+ T cell responses and enhanced sensitivity to immune checkpoint blockade [PMID:25931171, PMID:35817971]. Homozygous loss-of-function of POLE causes a chromosome instability syndrome with growth retardation, microcephaly, immune deficiency, and myelodysplasia [PMID:25948378]."},"prefetch_data":{"uniprot":{"accession":"Q07864","full_name":"DNA polymerase epsilon catalytic subunit A","aliases":["3'-5' exodeoxyribonuclease","DNA polymerase II subunit A"],"length_aa":2286,"mass_kda":261.5,"function":"Catalytic component of the DNA polymerase epsilon complex (PubMed:10801849). Participates in chromosomal DNA replication (By similarity). Required during synthesis of the leading DNA strands at the replication fork, binds at/or near replication origins and moves along DNA with the replication fork (By similarity). Has 3'-5' proofreading exonuclease activity that corrects errors arising during DNA replication (By similarity). Involved in DNA synthesis during DNA repair (PubMed:20227374, PubMed:27573199). Along with DNA polymerase POLD1 and DNA polymerase POLK, has a role in excision repair (NER) synthesis following UV irradiation (PubMed:20227374)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q07864/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/POLE","classification":"Common Essential","n_dependent_lines":1204,"n_total_lines":1208,"dependency_fraction":0.9966887417218543},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"FKBP5","stoichiometry":0.2},{"gene":"PTGES3","stoichiometry":0.2},{"gene":"SSRP1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/POLE","total_profiled":1310},"omim":[{"mim_id":"621558","title":"RETINAL DYSTROPHY, ZEITZ-HAN TYPE; RDZH","url":"https://www.omim.org/entry/621558"},{"mim_id":"621398","title":"CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 100; CFAP100","url":"https://www.omim.org/entry/621398"},{"mim_id":"621371","title":"ENHANCED S-CONE SYNDROME 2; ESCS2","url":"https://www.omim.org/entry/621371"},{"mim_id":"621208","title":"CHROMOSOME 19 OPEN READING FRAME 44; C19ORF44","url":"https://www.omim.org/entry/621208"},{"mim_id":"621033","title":"NUP210-LIKE PROTEIN; NUP210L","url":"https://www.omim.org/entry/621033"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Nucleoplasm","reliability":"Enhanced"},{"location":"Plasma membrane","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"bone marrow","ntpm":20.8}],"url":"https://www.proteinatlas.org/search/POLE"},"hgnc":{"alias_symbol":["POLE1"],"prev_symbol":[]},"alphafold":{"accession":"Q07864","domains":[{"cath_id":"3.30.342.10","chopping":"46-197_213-268","consensus_level":"medium","plddt":85.2687,"start":46,"end":268},{"cath_id":"3.30.420.10","chopping":"271-472","consensus_level":"medium","plddt":89.9266,"start":271,"end":472},{"cath_id":"-","chopping":"535-677_736-938","consensus_level":"medium","plddt":89.2848,"start":535,"end":938},{"cath_id":"1.10.132.60","chopping":"960-1168","consensus_level":"medium","plddt":87.1165,"start":960,"end":1168},{"cath_id":"-","chopping":"1487-1650","consensus_level":"high","plddt":85.1515,"start":1487,"end":1650},{"cath_id":"-","chopping":"2152-2195","consensus_level":"medium","plddt":70.5066,"start":2152,"end":2195},{"cath_id":"-","chopping":"2200-2285","consensus_level":"high","plddt":82.7156,"start":2200,"end":2285}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q07864","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q07864-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q07864-F1-predicted_aligned_error_v6.png","plddt_mean":79.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=POLE","jax_strain_url":"https://www.jax.org/strain/search?query=POLE"},"sequence":{"accession":"Q07864","fasta_url":"https://rest.uniprot.org/uniprotkb/Q07864.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q07864/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q07864"}},"corpus_meta":[{"pmid":"23263490","id":"PMC_23263490","title":"Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas.","date":"2012","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23263490","citation_count":770,"is_preprint":false},{"pmid":"10220403","id":"PMC_10220403","title":"Rapid pole-to-pole oscillation of a protein required for directing division to the middle of Escherichia coli.","date":"1999","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10220403","citation_count":568,"is_preprint":false},{"pmid":"2384213","id":"PMC_2384213","title":"Posterior localization of vasa protein correlates with, but is not sufficient for, pole cell development.","date":"1990","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/2384213","citation_count":345,"is_preprint":false},{"pmid":"31829442","id":"PMC_31829442","title":"Interpretation of somatic POLE mutations in endometrial carcinoma.","date":"2020","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/31829442","citation_count":323,"is_preprint":false},{"pmid":"27159395","id":"PMC_27159395","title":"Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer.","date":"2016","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/27159395","citation_count":315,"is_preprint":false},{"pmid":"11526087","id":"PMC_11526087","title":"Aubergine encodes a Drosophila polar granule component required for pole cell formation and related to eIF2C.","date":"2001","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11526087","citation_count":275,"is_preprint":false},{"pmid":"11734639","id":"PMC_11734639","title":"Pattern formation in Escherichia coli: a model for the pole-to-pole oscillations of Min proteins and the localization of the division site.","date":"2001","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11734639","citation_count":268,"is_preprint":false},{"pmid":"18805088","id":"PMC_18805088","title":"A polymeric protein anchors the chromosomal origin/ParB complex at a bacterial cell pole.","date":"2008","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/18805088","citation_count":256,"is_preprint":false},{"pmid":"15473833","id":"PMC_15473833","title":"The budding yeast spindle pole body: structure, duplication, and function.","date":"2004","source":"Annual review of cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/15473833","citation_count":231,"is_preprint":false},{"pmid":"20890279","id":"PMC_20890279","title":"WDR62 is associated with the spindle pole and is mutated in human microcephaly.","date":"2010","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20890279","citation_count":228,"is_preprint":false},{"pmid":"10783235","id":"PMC_10783235","title":"The molecular motor dynein is involved in targeting swallow and bicoid RNA to the anterior pole of Drosophila oocytes.","date":"2000","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/10783235","citation_count":207,"is_preprint":false},{"pmid":"11932022","id":"PMC_11932022","title":"The anterior heart-forming field: voyage to the arterial pole of the heart.","date":"2002","source":"Trends in genetics : TIG","url":"https://pubmed.ncbi.nlm.nih.gov/11932022","citation_count":193,"is_preprint":false},{"pmid":"23045668","id":"PMC_23045668","title":"Pole-to-pole biogeography of surface and deep marine bacterial communities.","date":"2012","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23045668","citation_count":192,"is_preprint":false},{"pmid":"23702412","id":"PMC_23702412","title":"Cytoarchitecture, probability maps and functions of the human frontal pole.","date":"2013","source":"NeuroImage","url":"https://pubmed.ncbi.nlm.nih.gov/23702412","citation_count":183,"is_preprint":false},{"pmid":"25394778","id":"PMC_25394778","title":"Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutations.","date":"2014","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/25394778","citation_count":163,"is_preprint":false},{"pmid":"10459013","id":"PMC_10459013","title":"Sid2p, a spindle pole body kinase that regulates the onset of cytokinesis.","date":"1999","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/10459013","citation_count":159,"is_preprint":false},{"pmid":"2497990","id":"PMC_2497990","title":"Centrosomes, and not nuclei, initiate pole cell formation in Drosophila embryos.","date":"1989","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/2497990","citation_count":155,"is_preprint":false},{"pmid":"12808028","id":"PMC_12808028","title":"RHAMM is a centrosomal protein that interacts with dynein and maintains spindle pole stability.","date":"2003","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/12808028","citation_count":149,"is_preprint":false},{"pmid":"24345373","id":"PMC_24345373","title":"How do bacteria localize proteins to the cell pole?","date":"2013","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/24345373","citation_count":144,"is_preprint":false},{"pmid":"25224212","id":"PMC_25224212","title":"Polymerase ɛ (POLE) mutations in endometrial cancer: clinical outcomes and implications for Lynch syndrome testing.","date":"2014","source":"Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/25224212","citation_count":144,"is_preprint":false},{"pmid":"11010907","id":"PMC_11010907","title":"Bacterial activity in South Pole snow.","date":"2000","source":"Applied and environmental microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/11010907","citation_count":143,"is_preprint":false},{"pmid":"23070816","id":"PMC_23070816","title":"A multidomain hub anchors the chromosome segregation and chemotactic machinery to the bacterial pole.","date":"2012","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/23070816","citation_count":138,"is_preprint":false},{"pmid":"24501277","id":"PMC_24501277","title":"New insights into POLE and POLD1 germline mutations in familial colorectal cancer and polyposis.","date":"2014","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24501277","citation_count":123,"is_preprint":false},{"pmid":"35143306","id":"PMC_35143306","title":"Mechanism of spindle pole organization and instability in human oocytes.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35143306","citation_count":115,"is_preprint":false},{"pmid":"26648449","id":"PMC_26648449","title":"Combined mismatch repair and POLE/POLD1 defects explain unresolved suspected Lynch syndrome cancers.","date":"2015","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/26648449","citation_count":107,"is_preprint":false},{"pmid":"23516109","id":"PMC_23516109","title":"Aurora at the pole and equator: overlapping functions of Aurora kinases in the mitotic spindle.","date":"2013","source":"Open biology","url":"https://pubmed.ncbi.nlm.nih.gov/23516109","citation_count":100,"is_preprint":false},{"pmid":"20368616","id":"PMC_20368616","title":"CDK5RAP2 functions in centrosome to spindle pole attachment and DNA damage response.","date":"2010","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/20368616","citation_count":100,"is_preprint":false},{"pmid":"32792570","id":"PMC_32792570","title":"Role of POLE and POLD1 in familial cancer.","date":"2020","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32792570","citation_count":99,"is_preprint":false},{"pmid":"26166783","id":"PMC_26166783","title":"Aurora A Kinase Contributes to a Pole-Based Error Correction Pathway.","date":"2015","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/26166783","citation_count":98,"is_preprint":false},{"pmid":"16272122","id":"PMC_16272122","title":"Regulated pole-to-pole oscillations of a bacterial gliding motility protein.","date":"2005","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/16272122","citation_count":97,"is_preprint":false},{"pmid":"30198841","id":"PMC_30198841","title":"Peptidoglycan precursor synthesis along the sidewall of pole-growing mycobacteria.","date":"2018","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/30198841","citation_count":96,"is_preprint":false},{"pmid":"35780178","id":"PMC_35780178","title":"POLE/POLD1 mutation and tumor immunotherapy.","date":"2022","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/35780178","citation_count":91,"is_preprint":false},{"pmid":"7774604","id":"PMC_7774604","title":"Cell adhesion to the apical pole of epithelium: a function of cell polarity.","date":"1995","source":"European journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/7774604","citation_count":90,"is_preprint":false},{"pmid":"15495201","id":"PMC_15495201","title":"Drosophila tudor is essential for polar granule assembly and pole cell specification, but not for posterior patterning.","date":"2004","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/15495201","citation_count":86,"is_preprint":false},{"pmid":"24778223","id":"PMC_24778223","title":"Bacterial scaffold directs pole-specific centromere segregation.","date":"2014","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/24778223","citation_count":85,"is_preprint":false},{"pmid":"17028581","id":"PMC_17028581","title":"Inhibitors of Polo-like kinase reveal roles in spindle-pole maintenance.","date":"2006","source":"Nature chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/17028581","citation_count":85,"is_preprint":false},{"pmid":"30150290","id":"PMC_30150290","title":"Macropinosome formation by tent pole ruffling in macrophages.","date":"2018","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/30150290","citation_count":81,"is_preprint":false},{"pmid":"11267871","id":"PMC_11267871","title":"Asymmetric spindle pole localization of yeast Cdc15 kinase links mitotic exit and cytokinesis.","date":"2001","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/11267871","citation_count":79,"is_preprint":false},{"pmid":"21865156","id":"PMC_21865156","title":"Biogenesis of the posterior pole is mediated by the exosome/microvesicle protein-sorting pathway.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21865156","citation_count":77,"is_preprint":false},{"pmid":"12445269","id":"PMC_12445269","title":"The distal pole complex: a novel membrane domain distal to the immunological synapse.","date":"2002","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/12445269","citation_count":74,"is_preprint":false},{"pmid":"25593304","id":"PMC_25593304","title":"From equator to pole: splitting chromosomes in mitosis and meiosis.","date":"2015","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/25593304","citation_count":70,"is_preprint":false},{"pmid":"20702561","id":"PMC_20702561","title":"Arterial pole progenitors interpret opposing FGF/BMP signals to proliferate or differentiate.","date":"2010","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/20702561","citation_count":70,"is_preprint":false},{"pmid":"24992682","id":"PMC_24992682","title":"zic-1 Expression in Planarian neoblasts after injury controls anterior pole regeneration.","date":"2014","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24992682","citation_count":70,"is_preprint":false},{"pmid":"25860647","id":"PMC_25860647","title":"A novel POLE mutation associated with cancers of colon, pancreas, ovaries and small intestine.","date":"2015","source":"Familial cancer","url":"https://pubmed.ncbi.nlm.nih.gov/25860647","citation_count":66,"is_preprint":false},{"pmid":"15629926","id":"PMC_15629926","title":"Caulobacter crescentus requires RodA and MreB for stalk synthesis and prevention of ectopic pole formation.","date":"2005","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/15629926","citation_count":65,"is_preprint":false},{"pmid":"30917185","id":"PMC_30917185","title":"Phenotype of POLE-mutated endometrial cancer.","date":"2019","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/30917185","citation_count":64,"is_preprint":false},{"pmid":"25931171","id":"PMC_25931171","title":"Polymerase ε (POLE) ultra-mutated tumors induce robust tumor-specific CD4+ T cell responses in endometrial cancer patients.","date":"2015","source":"Gynecologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/25931171","citation_count":64,"is_preprint":false},{"pmid":"22116936","id":"PMC_22116936","title":"Identification of a Tbx1/Tbx2/Tbx3 genetic pathway governing pharyngeal and arterial pole morphogenesis.","date":"2011","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22116936","citation_count":61,"is_preprint":false},{"pmid":"35817971","id":"PMC_35817971","title":"Functional landscapes of POLE and POLD1 mutations in checkpoint blockade-dependent antitumor immunity.","date":"2022","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/35817971","citation_count":60,"is_preprint":false},{"pmid":"24788313","id":"PMC_24788313","title":"A mutation in POLE predisposing to a multi-tumour phenotype.","date":"2014","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/24788313","citation_count":59,"is_preprint":false},{"pmid":"32497495","id":"PMC_32497495","title":"POLE Mutation Spectra Are Shaped by the Mutant Allele Identity, Its Abundance, and Mismatch Repair Status.","date":"2020","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/32497495","citation_count":58,"is_preprint":false},{"pmid":"27894751","id":"PMC_27894751","title":"Polymerase ε (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro.","date":"2016","source":"Gynecologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/27894751","citation_count":58,"is_preprint":false},{"pmid":"9060463","id":"PMC_9060463","title":"The yeast CDC37 gene interacts with MPS1 and is required for proper execution of spindle pole body duplication.","date":"1997","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/9060463","citation_count":57,"is_preprint":false},{"pmid":"38777726","id":"PMC_38777726","title":"Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancer.","date":"2024","source":"Annals of oncology : official journal of the European Society for Medical Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/38777726","citation_count":55,"is_preprint":false},{"pmid":"14528012","id":"PMC_14528012","title":"The chromokinesin, KLP3A, dives mitotic spindle pole separation during prometaphase and anaphase and facilitates chromatid motility.","date":"2003","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/14528012","citation_count":55,"is_preprint":false},{"pmid":"31757464","id":"PMC_31757464","title":"Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer.","date":"2019","source":"Gynecologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/31757464","citation_count":54,"is_preprint":false},{"pmid":"18663358","id":"PMC_18663358","title":"Aurora-A and ch-TOG act in a common pathway in control of spindle pole integrity.","date":"2008","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/18663358","citation_count":52,"is_preprint":false},{"pmid":"30818169","id":"PMC_30818169","title":"POLE proofreading defects: Contributions to mutagenesis and cancer.","date":"2019","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/30818169","citation_count":50,"is_preprint":false},{"pmid":"12828633","id":"PMC_12828633","title":"A lytic transglycosylase homologue, PleA, is required for the assembly of pili and the flagellum at the Caulobacter crescentus cell pole.","date":"2003","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/12828633","citation_count":50,"is_preprint":false},{"pmid":"15612921","id":"PMC_15612921","title":"The type IV secretion apparatus protein VirB6 of Agrobacterium tumefaciens localizes to a cell pole.","date":"2005","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/15612921","citation_count":50,"is_preprint":false},{"pmid":"25047610","id":"PMC_25047610","title":"Lessons from yeast: the spindle pole body and the centrosome.","date":"2014","source":"Philosophical transactions of the Royal Society of London. Series B, Biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/25047610","citation_count":47,"is_preprint":false},{"pmid":"23318641","id":"PMC_23318641","title":"pbx is required for pole and eye regeneration in planarians.","date":"2013","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/23318641","citation_count":45,"is_preprint":false},{"pmid":"31673068","id":"PMC_31673068","title":"Comprehensive analysis of POLE and POLD1 Gene Variations identifies cancer patients potentially benefit from immunotherapy in Chinese population.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31673068","citation_count":44,"is_preprint":false},{"pmid":"35927456","id":"PMC_35927456","title":"A root phloem pole cell atlas reveals common transcriptional states in protophloem-adjacent cells.","date":"2022","source":"Nature plants","url":"https://pubmed.ncbi.nlm.nih.gov/35927456","citation_count":44,"is_preprint":false},{"pmid":"28423643","id":"PMC_28423643","title":"POLE and POLD1 screening in 155 patients with multiple polyps and early-onset colorectal cancer.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28423643","citation_count":43,"is_preprint":false},{"pmid":"29120461","id":"PMC_29120461","title":"Risk of colorectal cancer for carriers of a germ-line mutation in POLE or POLD1.","date":"2017","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29120461","citation_count":43,"is_preprint":false},{"pmid":"17276919","id":"PMC_17276919","title":"Mechanisms of spindle-pole organization are influenced by kinetochore activity in mammalian cells.","date":"2007","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/17276919","citation_count":42,"is_preprint":false},{"pmid":"34607897","id":"PMC_34607897","title":"Distinct mutational profile and immune microenvironment in microsatellite-unstable and POLE-mutated tumors.","date":"2021","source":"Journal for immunotherapy of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/34607897","citation_count":40,"is_preprint":false},{"pmid":"35927716","id":"PMC_35927716","title":"Yeast osmoregulation - glycerol still in pole position.","date":"2022","source":"FEMS yeast research","url":"https://pubmed.ncbi.nlm.nih.gov/35927716","citation_count":39,"is_preprint":false},{"pmid":"29572003","id":"PMC_29572003","title":"Clinicopathological characteristics of POLE mutation in patients with non-small-cell lung cancer.","date":"2018","source":"Lung cancer (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/29572003","citation_count":39,"is_preprint":false},{"pmid":"26493165","id":"PMC_26493165","title":"GREM1 and POLE variants in hereditary colorectal cancer syndromes.","date":"2015","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/26493165","citation_count":38,"is_preprint":false},{"pmid":"33715893","id":"PMC_33715893","title":"Tumor-infiltrating lymphocytes and POLE mutation in endometrial carcinoma.","date":"2021","source":"Gynecologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/33715893","citation_count":36,"is_preprint":false},{"pmid":"10821171","id":"PMC_10821171","title":"A spindle pole body-associated protein, SNAD, affects septation and conidiation in Aspergillus nidulans.","date":"2000","source":"Molecular & general genetics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/10821171","citation_count":36,"is_preprint":false},{"pmid":"31974342","id":"PMC_31974342","title":"A biphasic growth model for cell pole elongation in mycobacteria.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31974342","citation_count":35,"is_preprint":false},{"pmid":"26324921","id":"PMC_26324921","title":"PopZ identifies the new pole, and PodJ identifies the old pole during polar growth in Agrobacterium tumefaciens.","date":"2015","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/26324921","citation_count":35,"is_preprint":false},{"pmid":"17709012","id":"PMC_17709012","title":"Expeditions to the pole: RNA localization in Xenopus and Drosophila.","date":"1997","source":"Trends in cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/17709012","citation_count":34,"is_preprint":false},{"pmid":"34531387","id":"PMC_34531387","title":"The biogeographic differentiation of algal microbiomes in the upper ocean from pole to pole.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34531387","citation_count":34,"is_preprint":false},{"pmid":"24963130","id":"PMC_24963130","title":"The KASH protein Kms2 coordinates mitotic remodeling of the spindle pole body.","date":"2014","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/24963130","citation_count":32,"is_preprint":false},{"pmid":"29659608","id":"PMC_29659608","title":"Clinical impact of endometrial cancer stratified by genetic mutational profiles, POLE mutation, and microsatellite instability.","date":"2018","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/29659608","citation_count":31,"is_preprint":false},{"pmid":"15330869","id":"PMC_15330869","title":"nanos expression at the embryonic posterior pole and the medusa phase in the hydrozoan Podocoryne carnea.","date":"2004","source":"Evolution & development","url":"https://pubmed.ncbi.nlm.nih.gov/15330869","citation_count":31,"is_preprint":false},{"pmid":"17878409","id":"PMC_17878409","title":"Dialogue between LKB1 and AMPK: a hot topic at the cellular pole.","date":"2007","source":"Science's STKE : signal transduction knowledge environment","url":"https://pubmed.ncbi.nlm.nih.gov/17878409","citation_count":30,"is_preprint":false},{"pmid":"24472300","id":"PMC_24472300","title":"Frequent POLE1 p.S297F mutation in Chinese patients with ovarian endometrioid carcinoma.","date":"2014","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/24472300","citation_count":29,"is_preprint":false},{"pmid":"26951196","id":"PMC_26951196","title":"Duplication of the Yeast Spindle Pole Body Once per Cell Cycle.","date":"2016","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/26951196","citation_count":29,"is_preprint":false},{"pmid":"31240875","id":"PMC_31240875","title":"Clinicopathological and mutational analyses of colorectal cancer with mutations in the POLE gene.","date":"2019","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31240875","citation_count":29,"is_preprint":false},{"pmid":"29361575","id":"PMC_29361575","title":"Nkx genes establish second heart field cardiomyocyte progenitors at the arterial pole and pattern the venous pole through Isl1 repression.","date":"2018","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/29361575","citation_count":28,"is_preprint":false},{"pmid":"11929974","id":"PMC_11929974","title":"The Saccharomyces cerevisiae Fin1 protein forms cell cycle-specific filaments between spindle pole bodies.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11929974","citation_count":28,"is_preprint":false},{"pmid":"31624068","id":"PMC_31624068","title":"Germline POLE mutation in a child with hypermutated medulloblastoma and features of constitutional mismatch repair deficiency.","date":"2019","source":"Cold Spring Harbor molecular case studies","url":"https://pubmed.ncbi.nlm.nih.gov/31624068","citation_count":27,"is_preprint":false},{"pmid":"28883092","id":"PMC_28883092","title":"Human microcephaly ASPM protein is a spindle pole-focusing factor that functions redundantly with CDK5RAP2.","date":"2017","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/28883092","citation_count":27,"is_preprint":false},{"pmid":"25948378","id":"PMC_25948378","title":"A patient with polymerase E1 deficiency (POLE1): clinical features and overlap with DNA breakage/instability syndromes.","date":"2015","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25948378","citation_count":26,"is_preprint":false},{"pmid":"39172836","id":"PMC_39172836","title":"Mechanisms of minor pole-mediated spindle bipolarization in human oocytes.","date":"2024","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/39172836","citation_count":25,"is_preprint":false},{"pmid":"29880869","id":"PMC_29880869","title":"Molecular profiling and sequential somatic mutation shift in hypermutator tumours harbouring POLE mutations.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29880869","citation_count":25,"is_preprint":false},{"pmid":"21179512","id":"PMC_21179512","title":"Targeting and anchoring Tudor in the pole plasm of the Drosophila oocyte.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21179512","citation_count":25,"is_preprint":false},{"pmid":"31479159","id":"PMC_31479159","title":"Morphological, immunophenotypical and molecular features of hypermutation in colorectal carcinomas with mutations in DNA polymerase ε (POLE).","date":"2019","source":"Histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/31479159","citation_count":23,"is_preprint":false},{"pmid":"31495582","id":"PMC_31495582","title":"Centromere Dysfunction Compromises Mitotic Spindle Pole Integrity.","date":"2019","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/31495582","citation_count":22,"is_preprint":false},{"pmid":"32627883","id":"PMC_32627883","title":"Genomic Alterations of NTRK, POLE, ERBB2, and Microsatellite Instability Status in Chinese Patients with Colorectal Cancer.","date":"2020","source":"The oncologist","url":"https://pubmed.ncbi.nlm.nih.gov/32627883","citation_count":22,"is_preprint":false},{"pmid":"31552169","id":"PMC_31552169","title":"Detection of POLE Subtypes in High-Grade Endometrioid Carcinoma by BaseScope-ISH Assay.","date":"2019","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/31552169","citation_count":21,"is_preprint":false},{"pmid":"23907121","id":"PMC_23907121","title":"Automated tracking of mitotic spindle pole positions shows that LGN is required for spindle rotation but not orientation maintenance.","date":"2013","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/23907121","citation_count":20,"is_preprint":false},{"pmid":"1617208","id":"PMC_1617208","title":"From egg to pole cells: ultrastructural aspects of early cleavage and germ cell determination in insects.","date":"1992","source":"Microscopy research and technique","url":"https://pubmed.ncbi.nlm.nih.gov/1617208","citation_count":20,"is_preprint":false},{"pmid":"31895686","id":"PMC_31895686","title":"CEP215 and AURKA regulate spindle pole focusing and aMTOC organization in mouse oocytes.","date":"2020","source":"Reproduction (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/31895686","citation_count":18,"is_preprint":false},{"pmid":"35020734","id":"PMC_35020734","title":"Analysis of HubP-dependent cell pole protein targeting in Vibrio cholerae uncovers novel motility regulators.","date":"2022","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/35020734","citation_count":17,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":44909,"output_tokens":2975,"usd":0.089676},"stage2":{"model":"claude-opus-4-6","input_tokens":6338,"output_tokens":2454,"usd":0.13956},"total_usd":0.229236,"stage1_batch_id":"msgbatch_01SUR8NDzVrNmyszWyJeCct7","stage2_batch_id":"msgbatch_01G7Yfutko3cDWzejrwH5AMx","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2012,\n      \"finding\": \"Germline mutations in the proofreading (exonuclease) domain of POLE (p.Leu424Val) cause defects in correction of mispaired bases inserted during DNA replication, leading to base substitution hypermutation in tumors while remaining microsatellite stable. Yeast functional assays confirmed loss of exonuclease proofreading activity.\",\n      \"method\": \"Whole-genome sequencing, linkage/association analysis, yeast functional assays for exonuclease activity\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — foundational paper with multiple orthogonal methods (WGS, functional yeast assay), highly cited, replicated across labs\",\n      \"pmids\": [\"23263490\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"POLE exonuclease domain mutations (EDMs) cause loss of proofreading function, generating a characteristic mutational signature including >20% C>A substitutions, >4% T>G substitutions, <0.6% C>G substitutions, and tumor mutational burden >100 mut/Mb. A scoring system (POLE-score) based on these genomic alterations distinguishes pathogenic from non-pathogenic POLE mutations. Mutations outside the exonuclease domain are predominantly not pathogenic.\",\n      \"method\": \"Whole-exome sequencing of TCGA endometrial carcinomas, mutational signature analysis, POLE-score development\",\n      \"journal\": \"The Journal of pathology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — systematic multi-parameter genomic analysis across large cohort, mechanistically defines pathogenic vs. non-pathogenic variants\",\n      \"pmids\": [\"31829442\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"POLE cancer mutant alleles drive characteristic mutational signature accumulation even in the presence of functional mismatch repair (MMR), unlike an exonuclease active-site mutant. The relative abundance of mutation signatures partitions POLE tumors into distinct subgroups dependent on the specific POLE allele, its expression level, and MMR status, revealing that different POLE mutants have distinct effects on replication fidelity.\",\n      \"method\": \"CRISPR-Cas9 engineering of human cell lines expressing POLE tumor variants with/without MMR, whole-exome sequencing after defined population doublings\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution in human cells with CRISPR engineering, quantitative mutation accumulation assay, multiple POLE alleles compared\",\n      \"pmids\": [\"32497495\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"POLE proofreading-deficient tumors accumulate extensive somatic mutations via loss of exonuclease proofreading activity during DNA replication. The proofreading domain of POLE corrects mispaired bases; mutations in this domain allow errors to persist, leading to hypermutation. MMR further modulates the mutational spectrum.\",\n      \"method\": \"Cancer genome sequencing, mutational signature analysis, review of yeast and mouse model data\",\n      \"journal\": \"DNA repair\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — comprehensive review integrating multiple independent experimental systems (yeast, mouse, human cells)\",\n      \"pmids\": [\"30818169\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"A novel POLE mutation (p.Tyr458Phe) located in the active site of the exonuclease domain affects a residue previously shown to be important for exonuclease activity, expanding the tumor spectrum of POLE mutation carriers to include cancers of colon, pancreas, ovaries, and small intestine.\",\n      \"method\": \"Exome sequencing, pedigree analysis, identification of active-site residue involved in exonuclease catalysis\",\n      \"journal\": \"Familial cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — exome sequencing with structural/functional annotation of active-site residue; single family\",\n      \"pmids\": [\"25860647\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"The POLE mutation p.Asn363Lys (c.1089C>A) is located in the proofreading exonuclease domain at a residue directly involved in DNA binding, predicted to profoundly affect substrate binding capability and catalytic activity of the exonuclease, leading to a broader tumor spectrum than p.Leu424Val.\",\n      \"method\": \"Sequencing, in silico structural prediction of amino acid substitution effect on DNA binding\",\n      \"journal\": \"International journal of oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — in silico prediction with family segregation data, no direct in vitro enzymatic assay\",\n      \"pmids\": [\"24788313\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"POLE exonuclease domain mutations generate ultra-mutated tumors with a high neoantigen load, inducing robust tumor-specific CD4+ T cell responses and a Th1 cytokine bias (IFN-γ), and significantly more immunogenic responses compared to POLE wild-type endometrial cancers.\",\n      \"method\": \"Autologous dendritic cell stimulation assay, CFSE proliferation assay, [3H]-thymidine incorporation, 51Cr cytotoxicity assay, intracellular cytokine flow cytometry\",\n      \"journal\": \"Gynecologic oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple in vitro functional immunological assays establishing mechanistic immunogenicity link; single lab\",\n      \"pmids\": [\"25931171\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"A POLE variant (c.1420G>A, p.Val474Ile) located adjacent to the exonuclease domain was shown by functional assays in Schizosaccharomyces pombe to impair proofreading activity, representing the first functional analysis of a POLE variant outside the canonical exonuclease domain.\",\n      \"method\": \"Sanger sequencing, bioinformatics prediction, S. pombe functional assay for proofreading activity\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — functional yeast assay validating proofreading defect; single study\",\n      \"pmids\": [\"28423643\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Pathogenic POLE/POLD1 mutations that cause functional proofreading deficiency generate specific mutational signatures and produce neoantigens with increased hydrophobicity at TCR-contact residues, facilitating T cell recognition and enhancing immune checkpoint blockade response. Murine syngeneic tumors with Pole/Pold1 functional mutations displayed enhanced antitumor immunity sensitive to ICB.\",\n      \"method\": \"Murine syngeneic tumor models, mutational signature analysis, biochemical analysis of neoantigen properties, patient ICB response correlation\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic study with animal models plus biochemical neoantigen characterization, published in high-impact journal\",\n      \"pmids\": [\"35817971\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Defective POLE proofreading leads to extensive somatic mutation accumulation following a temporally ordered pattern: mutations in cancer-related genes occur before the aberrant POLE event, PTEN mutations co-occur with or follow POLE mutations, and homologous recombination is restored after PTEN mutation, suggesting POLE and PTEN cooperate in tumorigenic development.\",\n      \"method\": \"Whole-exome sequencing of 10 POLE-mutated solid tumors, sequential mutation shift analysis\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — systematic genomic analysis establishing temporal ordering of mutational events; single cohort\",\n      \"pmids\": [\"29880869\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"POLE exonuclease domain mutations co-occurring with MMR deficiency/MSI-H produce genomic alterations characteristic of POLE-ultramutated tumors, indicating that the POLE proofreading defect is dominant over MMR deficiency in determining the mutational phenotype when both are present.\",\n      \"method\": \"Exome sequencing, MMR protein IHC, MSI analysis, mutational signature analysis in combined MMR-deficient/POLE-mutated tumors\",\n      \"journal\": \"European journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — epistasis established by combined molecular analysis; moderate sample size\",\n      \"pmids\": [\"26648449\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"A patient with homozygous POLE1 (catalytic subunit of DNA polymerase epsilon) splice variant (c.4444+3A>G) presented with growth retardation, microcephaly, developmental delay, immune deficiency with pancytopenia, and myelodysplasia, demonstrating that complete loss of POLE1 function causes a chromosome instability syndrome in humans.\",\n      \"method\": \"Exome sequencing, clinical phenotyping\",\n      \"journal\": \"BMC medical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — human loss-of-function with defined clinical/cellular phenotype; single patient report\",\n      \"pmids\": [\"25948378\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"POLE somatic exonuclease domain mutations (including P286R, V411L) define an ultramutated endometrial carcinoma subtype characterized by microsatellite stability, high tumor mutation rate, and distinct co-mutations in PTEN, FBXW7, ARID1A, and PIK3CA, establishing POLE proofreading defects as a driver of hypermutation distinct from MMR deficiency.\",\n      \"method\": \"Sanger sequencing of POLE exonuclease domain, TCGA whole-exome sequencing data analysis, microsatellite stability testing\",\n      \"journal\": \"Modern pathology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — systematic molecular characterization across TCGA cohort plus independent validation cohort, replicated\",\n      \"pmids\": [\"25394778\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"POLE encodes the catalytic subunit of DNA polymerase epsilon, which functions in leading-strand DNA replication and possesses an intrinsic 3'→5' proofreading exonuclease activity; missense mutations in the exonuclease domain abolish proofreading of mispaired bases, causing extreme hypermutation with a characteristic mutational signature (enriched for C>A and T>G transversions, MSS), while the identity of the specific mutant allele, its expression level, and concurrent MMR status modulate the exact spectrum and burden of accumulated mutations, and the resulting neoantigen load drives enhanced immunogenicity and response to immune checkpoint blockade.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"POLE encodes the catalytic subunit of DNA polymerase epsilon, which carries out leading-strand DNA replication and harbors an intrinsic 3'→5' exonuclease domain that proofreads mispaired bases during synthesis. Germline or somatic missense mutations in the exonuclease domain—such as p.Leu424Val, P286R, and V411L—abolish proofreading activity, producing microsatellite-stable, ultramutated tumors (>100 mut/Mb) with a characteristic mutational signature enriched for C>A and T>G transversions; the specific mutant allele, its expression level, and concurrent mismatch repair status determine the exact mutational spectrum and burden [PMID:23263490, PMID:32497495, PMID:31829442, PMID:25394778]. The resulting high neoantigen load, including neoantigens with increased hydrophobicity at TCR-contact residues, drives robust CD4+ T cell responses and enhanced sensitivity to immune checkpoint blockade [PMID:25931171, PMID:35817971]. Homozygous loss-of-function of POLE causes a chromosome instability syndrome with growth retardation, microcephaly, immune deficiency, and myelodysplasia [PMID:25948378].\",\n  \"teleology\": [\n    {\n      \"year\": 2012,\n      \"claim\": \"Establishing that germline POLE exonuclease domain mutations (p.Leu424Val) cause loss of proofreading during replication answered the foundational question of how proofreading polymerase defects drive base-substitution hypermutation without microsatellite instability.\",\n      \"evidence\": \"Whole-genome sequencing of familial colorectal cancer kindreds plus yeast functional assays confirming exonuclease activity loss\",\n      \"pmids\": [\"23263490\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mechanism by which specific residue substitutions differentially affect polymerase fidelity was not resolved\",\n        \"Spectrum of pathogenic versus non-pathogenic POLE variants not yet delineated\",\n        \"Contribution of MMR as a secondary correction mechanism not quantified\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Systematic molecular characterization of endometrial carcinomas showed that somatic POLE exonuclease domain mutations (P286R, V411L) define an ultramutated tumor subtype mechanistically distinct from MMR-deficient tumors, establishing POLE proofreading defects as an independent driver of hypermutation in sporadic cancer.\",\n      \"evidence\": \"Sanger sequencing plus TCGA whole-exome data with microsatellite stability testing in endometrial carcinoma cohorts\",\n      \"pmids\": [\"25394778\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No direct enzymatic measurement of polymerase fidelity for the somatic mutants in human cells\",\n        \"Cooperative role of co-mutated genes (PTEN, PIK3CA) not mechanistically tested\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstrating that POLE-ultramutated tumors generate high neoantigen loads eliciting robust CD4+ Th1 immune responses linked POLE proofreading deficiency to tumor immunogenicity, answering why these hypermutated cancers paradoxically have favorable outcomes.\",\n      \"evidence\": \"Autologous dendritic cell stimulation, CFSE proliferation, 51Cr cytotoxicity, and intracellular cytokine assays in POLE-mutant versus wild-type endometrial cancers\",\n      \"pmids\": [\"25931171\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"CD8+ cytotoxic responses and in vivo immune killing not directly measured\",\n        \"Contribution of specific neoantigens versus total burden not dissected\",\n        \"Single-lab study without independent replication\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"A homozygous POLE splice variant causing complete loss of function resulted in a chromosome instability syndrome with microcephaly, immune deficiency, and myelodysplasia, establishing that POLE is essential for normal human development beyond its cancer-proofreading role.\",\n      \"evidence\": \"Exome sequencing and clinical phenotyping of a single patient with homozygous POLE1 splice variant\",\n      \"pmids\": [\"25948378\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single patient; no complementation or rescue experiment performed\",\n        \"Whether the developmental phenotype reflects replication defects, DNA repair defects, or both is unresolved\",\n        \"Cellular mechanism of chromosome instability not characterized\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Epistasis analysis showed that when POLE exonuclease domain mutations co-occur with MMR deficiency, the POLE mutational signature dominates, establishing the hierarchical relationship between these two DNA fidelity mechanisms.\",\n      \"evidence\": \"Exome sequencing, MMR protein IHC, MSI analysis, and mutational signature comparison in doubly-deficient tumors\",\n      \"pmids\": [\"26648449\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Mechanism of dominance (e.g., error rate versus error type) not dissected biochemically\",\n        \"Limited sample size of concurrent POLE/MMR-deficient cases\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"CRISPR-engineered human cells expressing specific POLE tumor variants revealed that different mutant alleles produce distinct mutational signatures even with intact MMR, resolving the question of whether allele identity or MMR status is the primary determinant of mutational spectrum.\",\n      \"evidence\": \"CRISPR-Cas9 knock-in of POLE variants in human cell lines with/without MMR, whole-exome sequencing after defined population doublings\",\n      \"pmids\": [\"32497495\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Biochemical basis for allele-specific signature differences (e.g., altered base selectivity) not determined\",\n        \"Long-term fitness consequences of different POLE alleles not assessed\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Development of the POLE-score system using signature-based genomic criteria (C>A >20%, T>G >4%, TMB >100 mut/Mb) distinguished pathogenic from non-pathogenic POLE variants, answering the variant-interpretation problem that had accumulated since the initial discovery.\",\n      \"evidence\": \"Systematic whole-exome sequencing analysis of TCGA endometrial carcinomas with mutational signature quantification\",\n      \"pmids\": [\"31829442\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"POLE-score validated only in endometrial cancer; applicability to other tumor types not established\",\n        \"No direct enzymatic assay validation of scored variants\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Mechanistic characterization of POLE/POLD1-driven neoantigens revealed increased hydrophobicity at TCR-contact residues, explaining enhanced T cell recognition and providing a biochemical basis for the exceptional immune checkpoint blockade response seen in POLE-mutant tumors.\",\n      \"evidence\": \"Murine syngeneic tumor models with Pole mutations, neoantigen biochemical property analysis, patient ICB response correlation\",\n      \"pmids\": [\"35817971\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether hydrophobicity-driven immunogenicity generalizes beyond the tested neoantigen repertoire is unclear\",\n        \"Relative contribution of POLE versus POLD1 neoantigens to immunogenicity not separated\",\n        \"No structural data on TCR–neoantigen interactions\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structural and biochemical basis by which individual POLE exonuclease domain substitutions differentially alter nucleotide selectivity and fidelity—and how the resulting mutational processes interact with chromatin context and replication timing—remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No high-resolution structure of human POLE holoenzyme with mutant exonuclease domain\",\n        \"Allele-specific differences in polymerase kinetics not measured in vitro with purified human enzyme\",\n        \"Relationship between replication timing, chromatin state, and POLE-driven mutagenesis not established\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140097\", \"supporting_discovery_ids\": [0, 2, 3]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 2, 11]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-69306\", \"supporting_discovery_ids\": [0, 2, 3, 12]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [0, 3]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [1, 2, 8, 12]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [6, 8]}\n    ],\n    \"complexes\": [\n      \"DNA polymerase epsilon\"\n    ],\n    \"partners\": [\n      \"POLD1\",\n      \"PTEN\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}